The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Sonic Healthcare (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis; Pfizer
Australian real-world outcomes of ribociclib and aromatase inhibitor in hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC): Results from Kisqali Access Registry for Metastatic breast cancer in Australia (KARMA) collected alongside a medicine access program.
 
Vanessa Wong
Consulting or Advisory Role - Amgen
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
 
Richard de Boer
Honoraria - Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
Speakers' Bureau - Genomic Health; Roche
 
Sally E. Baron-Hay
Consulting or Advisory Role - AstraZeneca; Merck Sharpe and Doehme; Novartis
 
Robert helmut Blum
No Relationships to Disclose
 
Benjamin Carl Forster
Honoraria - Lilly
Travel, Accommodations, Expenses - Genentech/Roche
 
Susan Li Ling Chua
No Relationships to Disclose
 
Katharine Cuff
No Relationships to Disclose
 
Michael Green
Consulting or Advisory Role - Roche
 
Elgene Lim
Consulting or Advisory Role - Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Travel, Accommodations, Expenses - Lilly
 
Kelly Mok
No Relationships to Disclose
 
Louise M. Nott
Honoraria - Merck Serono
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Novartis; Novartis; Roche
 
Michelle K. Nottage
No Relationships to Disclose
 
Ali Tafreshi
No Relationships to Disclose
 
Daphne T. F. Tsoi
Consulting or Advisory Role - Lilly
 
Belinda Yeo
Consulting or Advisory Role - Amgen; AstraZeneca; Genentech/Roche; Novartis
Speakers' Bureau - Eisai; Myriad Genetics; Novartis; Roche; Specialised Therapeutics
Travel, Accommodations, Expenses - Novartis; Roche
 
Peter Gibbs
Honoraria - Amgen; Merck; MSD Oncology; Roche; Sanofi/Aventis; SERVIER
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst); Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Servier
 
Sheau Wen Lok
Research Funding - Amgen (Inst); AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Annual royalties from WEHI for sale of patent to Roche Genentech - venetoclax